Mackay Shields LLC’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-31,000
Closed -$1.05M 1479
2021
Q1
$1.05M Sell
31,000
-20,100
-39% -$688K 0.01% 983
2020
Q4
$1.53M Sell
51,100
-8,300
-14% -$200K 0.01% 949
2020
Q3
$983K Sell
59,400
-21,000
-26% -$365K 0.01% 1036
2020
Q2
$1.09M Sell
80,400
-8,700
-10% -$96.3K 0.01% 993
2020
Q1
$576K Sell
89,100
-35,800
-29% -$585K 0.01% 1102
2019
Q4
$2.56M Buy
124,900
+94,500
+311% +$1.96M 0.02% 768
2019
Q3
$758K Buy
+30,400
New +$649K ﹤0.01% 1185

Other funds holding LDL

Mackay Shields LLC's LDL Position: Q2 2021 in Review

Mackay Shields LLC sold out of Lydall, Inc. (LDL) in Q2 2021, closing a stake of 31,000 shares — an estimated $1.05M sold.

Mackay Shields LLC first reported a position in LDL in Q3 2019 and held it in 7 quarters. The position peaked at $2.56M in Q4 2019. 157 funds tracked by Wall St. Rank hold LDL as of Q2 2021.

  • Mackay Shields LLC reported no remaining Lydall, Inc. position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 31,000 Lydall, Inc. shares in Q2 2021, an estimated $1.05M.
  • Mackay Shields LLC first reported a position in Lydall, Inc. in Q3 2019 and held it in 7 quarters.
  • Mackay Shields LLC's Lydall, Inc. position peaked at $2.56M in Q4 2019.
  • 157 funds tracked by Wall St. Rank held Lydall, Inc. as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.